Trilaciclib hydrochloride
CAS: 1977495-97-8
Ref. 3D-CED49597
| 1mg | 738,00 € | ||
| 2mg | 1.081,00 € | ||
| 5mg | 1.929,00 € | ||
| 10mg | 2.469,00 € | ||
| 25mg | 3.704,00 € |
Información del producto
Trilaciclib is a small molecule that inhibits the CDK4/6 complex and is an inhibitor of cell proliferation. It has been shown to inhibit cancer growth in vitro, in vivo, and in humans. Trilaciclib is currently being tested as a treatment for hormone-dependent breast cancer. The drug works by targeting the microenvironment and inhibiting fibroblast growth factor (FGF) from binding to its receptor on the surface of cells. This leads to cell death through apoptosis and immunogenic cell death, which can be used for the treatment of tumors. Trilaciclib also enhances natural killer cell activity, which may help with cancer patients’ immunity against tumor cells.
Propiedades químicas
Consulta técnica sobre: 3D-CED49597 Trilaciclib hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
